New Prenatal Vitamin Targets Critical Nutrient for Baby's Brain Health

MARINA DEL REY, CA – March 16, 2026 – SmartyPants Vitamins, a prominent brand in the family nutrition space, has launched a new prenatal multivitamin that places a significant focus on a nutrient often overlooked in prenatal care: choline. The new SmartyPants Prenatal Plus Multivitamin Capsules, co-developed with an OB-GYN, are designed to address a critical nutritional shortfall that affects the vast majority of expectant mothers and plays a vital role in fetal brain development.

This launch enters a competitive market not just as another supplement, but as a direct response to growing scientific consensus and updated clinical guidance that highlights the widespread inadequacy of choline intake among pregnant women in the United States.

Closing the Widespread Choline Gap

For decades, prenatal nutrition has been dominated by conversations around folate and iron, both essential for preventing birth defects and supporting maternal health. However, emerging research has cast a bright light on choline, an essential nutrient indispensable for fetal brain and spinal cord development, as well as neurotransmitter function. Despite its importance, national health data reveals a startling deficiency.

According to analyses of the National Health and Nutrition Examination Survey (NHANES), more than 90% of pregnant women in the U.S. fail to meet the recommended adequate intake of 450 milligrams of choline per day. This significant gap persists despite dietary intake, highlighting a public health challenge. The consequences of insufficient choline can be serious, with studies linking low levels to a higher risk of neural tube defects and potential long-term impacts on a child's cognitive function.

In response to this, the American Medical Association (AMA) has previously called for prenatal vitamins to include evidence-based amounts of choline. Yet, a market review shows that many of the most popular prenatal supplements contain little to no choline, or amounts that fall far short of recommendations. A 2022 evaluation found that of the prenatal supplements that did include choline, the median amount was just 25 mg per serving. SmartyPants' new capsule directly confronts this issue by delivering 480 milligrams of choline per daily dose, a level that aligns with national guidelines for pregnancy.

"We designed SmartyPants Prenatal Plus Multivitamin Capsules around the real-world needs of women and babies, and grounded in evidence-based nutrition science," said Devyani Chaturvedi, Senior Nutrition Research Scientist at SmartyPants Vitamins, in a statement. The formulation aims to move beyond minimal inclusion to provide intentional, research-aligned nutrient levels.

How OB-GYN Collaboration is Elevating Supplement Science

The development of the new prenatal vitamin highlights a growing trend in the supplement industry: the direct collaboration between brands and medical professionals to create more clinically informed products. SmartyPants partnered with Dr. Michelle Tsai, a board-certified OB-GYN and member of the brand’s Scientific Advisory Board, to co-develop the formula.

This collaboration aims to lend medical credibility and ensure the product reflects the latest clinical research. "In prenatal care, decisions should be guided by the strength of the evidence, not trends or convenience," stated Dr. Tsai. "Women deserve clear, high-quality formulas that reflect the latest research, especially during pregnancy, when nutrition is a critical part of clinical decision making."

The emphasis on scientific rigor extends beyond choline. The formula includes other premium, easily absorbed nutrients, such as folate in its methylated form (methylfolate), which can be more readily used by the body than traditional folic acid. It also uses Ferrochel® iron, a form clinically shown to be gentle on the stomach and reduce the digestive side effects that often cause women to stop taking prenatal vitamins.

Further bolstering its commitment to quality, the brand subjects every batch to third-party testing. For expectant mothers often dealing with morning sickness, the capsules also feature neutral scent technology, a thoughtful detail designed to improve adherence during a time of heightened sensitivity to smells and tastes.

A Strategic Move in a Booming Prenatal Market

The launch represents a calculated strategic move by SmartyPants and its parent company, Unilever, in the rapidly expanding prenatal vitamin market. This global market, valued in the billions, is projected to grow at a compound annual rate of over 10% in the coming years, driven by increasing maternal age, greater health awareness, and a rising focus on preventative care.

In this crowded space, differentiation is key. By focusing on the significant and well-documented choline gap, SmartyPants carves out a distinct niche. The claim of providing "8x more" choline than the leading prenatal capsule is a powerful marketing tool, and one that holds up against many competitors whose choline content, if present at all, often hovers between 50 mg and 110 mg. This positions the product as a premium, science-forward option for consumers who are increasingly educated about specific nutritional needs.

This new capsule also allows the brand to cater to a wider range of consumer preferences. While SmartyPants is well-known for its popular gummy vitamins, the capsule format appeals to consumers looking to avoid the sugar content found in gummies or who prefer a more traditional supplement form. The simple two-capsule daily dose, which can be taken with or without food, adds another layer of convenience.

The distribution strategy—launching on Amazon and rolling out to select Target locations—ensures broad and immediate access for a large segment of the consumer market. This move leverages major retail channels to bring a specialized, science-backed product directly to the mainstream, potentially influencing consumer expectations and raising the bar for what is considered a comprehensive prenatal supplement.